Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 450 million people living with diabetes.

 

Top 5 shareholders

Updated October 5, 2021
Name
Holdings
Share
Citizen
Teigland Eiendom AS
14 809 477
17.95 %
NOR
Lacal AS
10 658 301
12.92 %
NOR
VPF Nordea Avkastning
6 662 700
8.03 %
NOR
Nordnet Livsforsikring AS
2 419 266
2.93 %
NOR
Westhawk AS
2 200 252
2.67 %
NOR
Swipe for more data

Contact

Investor relations

Kine Hereid

Head of Investor Relations